The mevalonate pathway and renal diseases: experimental and clinical implications.
A
A
Scoppola
P
P
Galiano
D000276:Adjuvants, Immunologic / Q000494:pharmacology; D000818:Animals; D002455:Cell Division / Q000502:physiology; D005057:Eukaryotic Cells / Q000378:metabolism; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000494:pharmacology; D007674:Kidney Diseases / Q000378:metabolism*; D007678:Kidney Glomerulus / Q000378:metabolism; D008798:Mevalonic Acid / Q000378:metabolism*
D000276:Adjuvants, Immunologic; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D008798:Mevalonic Acid